AR027291A1 - Atenuacion recombinante de prrsv - Google Patents

Atenuacion recombinante de prrsv

Info

Publication number
AR027291A1
AR027291A1 ARP010100333A ARP010100333A AR027291A1 AR 027291 A1 AR027291 A1 AR 027291A1 AR P010100333 A ARP010100333 A AR P010100333A AR P010100333 A ARP010100333 A AR P010100333A AR 027291 A1 AR027291 A1 AR 027291A1
Authority
AR
Argentina
Prior art keywords
orf
viruses
prrsv
recombinating
attention
Prior art date
Application number
ARP010100333A
Other languages
English (en)
Spanish (es)
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000103371 external-priority patent/DE10003371A1/de
Priority claimed from DE2000103372 external-priority patent/DE10003372A1/de
Priority claimed from DE2000103373 external-priority patent/DE10003373A1/de
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of AR027291A1 publication Critical patent/AR027291A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
ARP010100333A 2000-01-26 2001-01-26 Atenuacion recombinante de prrsv AR027291A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2000103371 DE10003371A1 (de) 2000-01-26 2000-01-26 Rekombinante Attenuation von PRRSV
DE2000103372 DE10003372A1 (de) 2000-01-26 2000-01-26 Rekombinante Attenuation von PRRSV
DE2000103373 DE10003373A1 (de) 2000-01-26 2000-01-26 Rekombinante Attenuation von PRRSV

Publications (1)

Publication Number Publication Date
AR027291A1 true AR027291A1 (es) 2003-03-19

Family

ID=27213605

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100333A AR027291A1 (es) 2000-01-26 2001-01-26 Atenuacion recombinante de prrsv

Country Status (15)

Country Link
EP (1) EP1254213A2 (pl)
JP (1) JP2003520601A (pl)
KR (1) KR20030032910A (pl)
CN (1) CN1406277A (pl)
AR (1) AR027291A1 (pl)
AU (1) AU2001228502A1 (pl)
BR (1) BR0107827A (pl)
CA (1) CA2396454A1 (pl)
CZ (1) CZ20022554A3 (pl)
EA (1) EA200200743A1 (pl)
HU (1) HUP0204176A3 (pl)
MX (1) MXPA02007198A (pl)
PL (1) PL356274A1 (pl)
SK (1) SK10932002A3 (pl)
WO (1) WO2001055353A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030082960A (ko) * 2001-03-09 2003-10-23 베링거잉겔하임베트메디카게엠베하 Ｐｒｒｓ 바이러스의 약독화된 생균 균주
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
WO2004085658A1 (en) 2003-03-27 2004-10-07 Ottawa Health Research Institute Mutant vesicular stomatitis viruses and use thereof
EP1856141A1 (en) * 2005-02-25 2007-11-21 Pfizer Products Inc. N protein mutants of porcine reproductive and respiratory syndrome virus
CN100439494C (zh) * 2007-03-14 2008-12-03 中国动物疫病预防控制中心 猪繁殖与呼吸综合征疫苗、制备方法及应用
US7666585B2 (en) 2007-06-15 2010-02-23 Protatek International, Inc. Construction of chimera PRRSV, compositions and vaccine preparations
CN101307305B (zh) * 2008-04-30 2010-06-16 中国动物疫病预防控制中心 一种猪繁殖与呼吸综合征病毒弱毒株及免疫原性物质和疫苗
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
JP6538071B2 (ja) * 2014-03-21 2019-07-03 ニューテック・ベンチャーズ 非天然発生のブタ生殖器呼吸器症候群ウイルス（ｐｒｒｓｖ）及び使用する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251397B1 (en) * 1992-10-30 2001-06-26 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same
ATE329616T1 (de) * 1994-08-05 2006-07-15 Univ Minnesota Virale nukleotidsequenz vr-2332 und nutzungsverfahren
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof

Also Published As

Publication number Publication date
JP2003520601A (ja) 2003-07-08
HUP0204176A2 (hu) 2003-04-28
AU2001228502A1 (en) 2001-08-07
EP1254213A2 (en) 2002-11-06
CN1406277A (zh) 2003-03-26
CZ20022554A3 (cs) 2002-10-16
HUP0204176A3 (en) 2003-12-29
KR20030032910A (ko) 2003-04-26
EA200200743A1 (ru) 2002-12-26
WO2001055353A3 (en) 2001-12-27
PL356274A1 (pl) 2004-06-28
CA2396454A1 (en) 2001-08-02
WO2001055353A2 (en) 2001-08-02
BR0107827A (pt) 2002-11-05
MXPA02007198A (es) 2002-12-09
SK10932002A3 (sk) 2002-11-06

Similar Documents

Publication Publication Date Title
BR0207988A (pt) Cepas atenuadas vivas de vìrus de prrs
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
ATE295180T1 (de) Zubereitung zur immunisierung gegen den aids- virus
BR9912178A (pt) Vacinas de peptìdeo sintéticas para febre aftosa
ATE327246T1 (de) Hepatitis c tripeptid inhibitoren
MXPA02011545A (es) Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
BR9712970A (pt) Método para produção de vacina para proteção contra virus sincitial respiratório, mistura de proteìna de fusão purificada, composição imunogênica
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
AR027291A1 (es) Atenuacion recombinante de prrsv
PE20020287A1 (es) Procedimiento para la purificacion de un antigeno del virus de la hepatitis b
EP1423137A4 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
AR004464A1 (es) Un metodo para producir una proteina de capside de papilomavirus
DK1149910T3 (da) Farmaceutisk præparat til behandling af papillomavirustumorer og -infektion
HUP9901958A2 (hu) Sertés reproduktív és respirációs szindróma vakcina
DK1334119T3 (da) Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet
ATE413888T1 (de) Salmonella vakzine
BRPI0411085A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de vìrus oncogênicos, e de condições ou distúrbios devidos a infecção por hpv
JP2006512078A5 (pl)
CL2009000791A1 (es) Compuestos derivados de labirintopeptina; procedimiento para prepararlos que comprende fermentar la cepa actinomadura namibiensis (dsm 6313); uso de los compuestos para tratar infecciones bacterianas, infecciones viricas y/o dolor; composicion farmaceutica que los comprenden; dna que codifica la preprolabirintopeptina a2.
RU2008144180A (ru) Вакцина против микоплазмы и prrsv
BR0014666A (pt) Vacina
HRP20100473T1 (hr) Imunostimulatorne kombinacije za profilaksu i liječenje hepatitisa c
UY26563A1 (es) Atenuación recombinante de prrsv
AR085800A1 (es) Vacuna de rinitis equina
ES2153284B1 (es) Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure